96
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Profiling the Expression of Circulating Acute-Phase Proteins, Cytokines, and Checkpoint Proteins in Patients with Severe Trauma: A Pilot Study

ORCID Icon, , , , , , , & ORCID Icon show all
Pages 3739-3753 | Published online: 06 Aug 2021

References

  • Gabay C, Kushner I, Epstein FH. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340(6):448–454. doi:10.1056/NEJM199902113400607
  • Gauldie J, Lamontagne L, Stadnyk A. Acute phase response in infectious disease. Surv Synth Pathol Res. 1985;4(2):126–151.
  • Renckens R, van Westerloo DJ, Roelofs JJTH, et al. Acute phase response impairs host defense against Pseudomonas aeruginosa pneumonia in mice. Crit Care Med. 2008;36(2):580–587. doi:10.1097/01.CCM.0B013E3181620652
  • Renckens R, Roelofs J, Knapp S, de Vos AF, Florquin S, van der Poll T. The acute-phase response and serum amyloid a inhibit the inflammatory response to Acinetobacter baumannii Pneumonia. J Infect Dis. 2006;193(2):187–195. doi:10.1086/498876
  • Di Battista AP, Rhind SG, Hutchison MG, et al. Inflammatory cytokine and chemokine profiles are associated with patient outcome and the hyperadrenergic state following acute brain injury. J Neuroinflammation. 2016;13:40. doi:10.1186/s12974-016-0500-3
  • Catania A, Lonati C, Sordi A, Gatti S. Detrimental consequences of brain injury on peripheral cells. Brain Behav Immun. 2009;23(7):877–884. doi:10.1016/j.bbi.2009.04.006
  • Miller ES, Loftus TJ, Kannan KB, Plazas JM, Efron PA, Mohr AM. Systemic regulation of bone marrow stromal cytokines after severe trauma. J Surg Res. 2019;243:220–228. doi:10.1016/j.jss.2019.05.033
  • Limoge M, Safina A, Beattie A, Kapus L, Truskinovsky AM, Bakin AV. Tumor-fibroblast interactions stimulate tumor vascularization by enhancing cytokine-driven production of MMP9 by tumor cells. Oncotarget. 2017;8(22):35592–35608. doi:10.18632/oncotarget.16022
  • Bible LE, Pasupuleti LV, Alzate WD, et al. Early propranolol administration to severely injured patients can improve bone marrow dysfunction. J Trauma Acute Care Surg. 2014;77(1):54–60. doi:10.1097/TA.0000000000000264
  • Alamo IG, Kannan KB, Loftus TJ, Ramos H, Efron PA, Mohr AM. Severe trauma and chronic stress activates extramedullary erythropoiesis. J Trauma Acute Care Surg. 2017;83(1):144–150. doi:10.1097/TA.0000000000001537
  • Millar JK, Kannan KB, Loftus TJ, et al. Persistent injury-associated anemia: the role of the bone marrow microenvironment. J Surg Res. 2017;214:240–246. doi:10.1016/j.jss.2017.03.018
  • Sears BW, Stover MD, Callaci J. Pathoanatomy and clinical correlates of the immunoinflammatory response following orthopaedic trauma. J Am Acad Orthop Surg. 2009;17(4):255–265. doi:10.5435/00124635-200904000-00006
  • Roberts CS, Pape HC, Jones AL, Malkani AL, Rodriguez JL, Giannoudis PV. Damage control orthopaedics: evolving concepts in the treatment of patients who have sustained orthopaedic trauma. Instr Course Lect. 2005;54:447–462.
  • Wigmore SJ, Fearon KC, Maingay JP, Lai PB, Ross JA. Interleukin-8 can mediate acute-phase protein production by isolated human hepatocytes. Am J Physiol. 1997;273(4):E720–E726.
  • Wakeley ME, Gray CC, Monaghan SF, Heffernan DS, Ayala A. Check point inhibitors and their role in immunosuppression in sepsis. Crit Care Clin. 2020;36(1):69–88. doi:10.1016/j.ccc.2019.08.006
  • Cai G, Freeman GJ. The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation. Immunol Rev. 2009;229(1):244–258. doi:10.1111/j.1600-065X.2009.00783.x
  • Patil NK, Luan L, Bohannon JK, Hernandez A, Guo Y, Sherwood ER. Frontline science: anti-PD-L1 protects against infection with common bacterial pathogens after burn injury. J Leukoc Biol. 2018;103(1):23–33. doi:10.1002/JLB.5HI0917-360R
  • Chen Q, Xu L, Du T, et al. Enhanced expression of PD-L1 on microglia after surgical brain injury exerts self-protection from inflammation and promotes neurological repair. Neurochem Res. 2019;44(11):2470–2481. doi:10.1007/s11064-019-02864-8
  • Yang W, Liu Y, Liu B, et al. Treatment of surgical brain injury by immune tolerance induced by intrathymic and hepatic portal vein injection of brain antigens. Sci Rep. 2016;6(1):32030. doi:10.1038/srep32030
  • Jeschke MG, Gauglitz GG, Finnerty CC, Kraft R, Mlcak RP, Herndon DN. Survivors versus nonsurvivors postburn: differences in inflammatory and hypermetabolic trajectories. Ann Surg. 2014;259(4):814–823. doi:10.1097/SLA.0b013e31828dfbf1
  • Hsu SY, Wu SC, Rau CS, et al. Impact of adapting the Abbreviated Injury Scale (AIS)-2005 from AIS-1998 on injury severity scores and clinical outcome. Int J Environ Res Public Health. 2019;16:24. doi:10.3390/ijerph16245033
  • Stewart KE, Cowan LD, Thompson DM. Changing to AIS 2005 and agreement of injury severity scores in a trauma registry with scores based on manual chart review. Injury. 2011;42(9):934–939. doi:10.1016/j.injury.2010.05.033
  • Newgard CD, Fu R, Lerner EB, et al. Deaths and high-risk trauma patients missed by standard trauma data sources. J Trauma Acute Care Surg. 2017;83(3):427–437. doi:10.1097/TA.0000000000001616
  • Hsieh CH, Hsu SY, Hsieh HY, Chen YC. Differences between the sexes in motorcycle-related injuries and fatalities at a Taiwanese level I trauma center. Biomed J. 2017;40(2):113–120. doi:10.1016/j.bj.2016.10.005
  • Hsieh CH, Liu HT, Hsu SY, Hsieh HY, Chen YC. Motorcycle-related hospitalizations of the elderly. Biomed J. 2017;40(2):121–128. doi:10.1016/j.bj.2016.10.006
  • Hsieh CH, Chen YC, Hsu SY, Hsieh HY, Chien PC. Defining polytrauma by abbreviated injury scale >/= 3 for a least two body regions is insufficient in terms of short-term outcome: a cross-sectional study at a level I trauma center. Biomed J. 2018;41(5):321–327. doi:10.1016/j.bj.2018.08.007
  • Champion HR, Sacco WJ, Copes WS, Gann DS, Gennarelli TA, Flanagan ME. A revision of the trauma score. J Trauma. 1989;29(5):623–629. doi:10.1097/00005373-198905000-00017
  • Fang H, Jiang W, Cheng J, et al. Balancing innate immunity and inflammatory state via modulation of neutrophil function: a novel strategy to fight sepsis. J Immunol Res. 2015;2015:187048. doi:10.1155/2015/187048
  • Tanaka H, Ishikawa K, Nishino M, Shimazu T, Yoshioka T. Changes in granulocyte colony-stimulating factor concentration in patients with trauma and sepsis. J Trauma. 1996;40(5):718–725;discussion 725–716. doi:10.1097/00005373-199605000-00006
  • Korkmaz S, Altuntas F. What is the role of biosimilar G-CSF agents in hematopoietic stem cell mobilization at present? Transfus Apher Sci. 2017;56(6):795–799.
  • Cook KM, Sifri ZC, Baranski GM, Mohr AM, Livingston DH. The role of plasma granulocyte colony stimulating factor and bone marrow dysfunction after severe trauma. J Am Coll Surg. 2013;216(1):57–64. doi:10.1016/j.jamcollsurg.2012.08.028
  • Presneill JJ, Waring PM, Layton JE, et al. Plasma granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: relation to disease severity, multiple organ dysfunction, and mortality. Crit Care Med. 2000;28(7):2344–2354. doi:10.1097/00003246-200007000-00028
  • Livingston DH, Anjaria D, Wu J, et al. Bone marrow failure following severe injury in humans. Ann Surg. 2003;238(5):748–753. doi:10.1097/01.sla.0000094441.38807.09
  • Cebon J, Layton JE, Maher D, Morstyn G. Endogenous haemopoietic growth factors in neutropenia and infection. Br J Haematol. 1994;86(2):265–274. doi:10.1111/j.1365-2141.1994.tb04725.x
  • Root RK, Dale DC. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients. J Infect Dis. 1999;179(Suppl 2):S342–S352. doi:10.1086/513857
  • Lieschke GJ, Grail D, Hodgson G, et al. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood. 1994;84(6):1737–1746. doi:10.1182/blood.V84.6.1737.1737
  • Hammond WP, Csiba E, Canin A, et al. Chronic neutropenia. A new canine model induced by human granulocyte colony-stimulating factor. J Clin Invest. 1991;87(2):704–710. doi:10.1172/JCI115049
  • Stephens DP, Fisher DA, Currie BJ. An audit of the use of granulocyte colony-stimulating factor in septic shock. Intern Med J. 2002;32(4):143–148. doi:10.1046/j.1445-5994.2002.00195.x
  • Almahmoud K, Namas RA, Abdul-Malak O, et al. Impact of injury severity on dynamic inflammation networks following blunt trauma. Shock. 2015;44(2):101–109. doi:10.1097/SHK.0000000000000395
  • Volpin G, Cohen M, Assaf M, Meir T, Katz R, Pollack S. Cytokine levels (IL-4, IL-6, IL-8 and TGFβ) as potential biomarkers of systemic inflammatory response in trauma patients. Int Orthop. 2014;38(6):1303–1309. doi:10.1007/s00264-013-2261-2
  • Wu JC, Livingston DH, Hauser CJ, Deitch EA, Rameshwar P. Trauma inhibits erythroid burst-forming unit and granulocyte-monocyte colony-forming unit growth through the production of TGF-beta1 by bone marrow stroma. Ann Surg. 2001;234(2):224–232. doi:10.1097/00000658-200108000-00013
  • Ulrich-Merzenich G, Hartbrod F, Kelber O, Müller J, Koptina A, Zeitler H. Salicylate-based phytopharmaceuticals induce adaptive cytokine and chemokine network responses in human fibroblast cultures. Phytomedicine. 2017;34:202–211. doi:10.1016/j.phymed.2017.08.002
  • Conti P, Ronconi G, Caraffa A, et al. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents. 2020;34(2):327–331.
  • Kumar M, Bhoi S. Impaired hematopoietic progenitor cells in trauma hemorrhagic shock. J Clin Orthop Trauma. 2016;7(4):282–285. doi:10.1016/j.jcot.2016.05.013
  • Santarsieri M, Kumar RG, Kochanek PM, Berga S, Wagner AK. Variable neuroendocrine-immune dysfunction in individuals with unfavorable outcome after severe traumatic brain injury. Brain Behav Immun. 2015;45:15–27. doi:10.1016/j.bbi.2014.09.003
  • Ziablitsev SV, Pishchulina SV, Kolesnikova SV, Boris RN. Systemic effects of unspecific inflammatory reaction at traumatic brain injury. Fiziol Zh. 2016;62(1):68–73. doi:10.15407/fz62.01.068
  • Del Aguila LF, Claffey KP, Kirwan JP. TNF-alpha impairs insulin signaling and insulin stimulation of glucose uptake in C2C12 muscle cells. Am J Physiol. 1999;276(5):E849–E855.
  • Cohen M, Meir T, Klein E, Volpin G, Assaf M, Pollack S. Cytokine levels as potential biomarkers for predicting the development of posttraumatic stress symptoms in casualties of accidents. Int J Psychiatry Med. 2011;42(2):117–131. doi:10.2190/PM.42.2.b
  • Pervanidou P, Kolaitis G, Charitaki S, et al. Elevated morning serum interleukin (IL)-6 or evening salivary cortisol concentrations predict posttraumatic stress disorder in children and adolescents six months after a motor vehicle accident. Psychoneuroendocrinology. 2007;32(8–10):991–999. doi:10.1016/j.psyneuen.2007.07.001
  • Pape HC, Rixen D, Morley J, et al. Impact of the method of initial stabilization for femoral shaft fractures in patients with multiple injuries at risk for complications (borderline patients). Ann Surg. 2007;246(3):491–499;discussion 499–501. doi:10.1097/SLA.0b013e3181485750
  • Qiao Z, Wang W, Yin L, et al. Using IL-6 concentrations in the first 24 h following trauma to predict immunological complications and mortality in trauma patients: a meta-analysis. Eur J Trauma Emerg Surg. 2018;44(5):679–687. doi:10.1007/s00068-017-0880-9
  • Bottazzi B, Doni A, Garlanda C, Mantovani A. An integrated view of humoral innate immunity: pentraxins as a paradigm. Annu Rev Immunol. 2010;28:157–183. doi:10.1146/annurev-immunol-030409-101305
  • Cho K, Pham TN, Crivello SD, Jeong J, Green TL, Greenhalgh DG. Involvement of CD14 and toll-like receptor 4 in the acute phase response of serum amyloid A proteins and serum amyloid P component in the liver after burn injury. Shock. 2004;21(2):144–150. doi:10.1097/01.shk.0000108398.56565.ae
  • De Buck M, Gouwy M, Wang JM, et al. Structure and expression of different Serum Amyloid A (SAA) variants and their concentration-dependent functions during host insults. Curr Med Chem. 2016;23(17):1725–1755. doi:10.2174/0929867323666160418114600
  • Sack GH Jr. Serum amyloid A - a review. Mol Med. 2018;24(1):46.
  • Noursadeghi M, Bickerstaff MC, Gallimore JR, Herbert J, Cohen J, Pepys MB. Role of serum amyloid P component in bacterial infection: protection of the host or protection of the pathogen. Proc Natl Acad Sci U S A. 2000;97(26):14584–14589. doi:10.1073/pnas.97.26.14584
  • Christie J, Markowsky SJ, Valdes C. Acute trauma alters morphine clearance. J Trauma. 1995;39(4):749–752. doi:10.1097/00005373-199510000-00026
  • Kuebler JF, Toth B, Yokoyama Y, Bland KI, Rue LW 3rd, Chaudry IH. Alpha1-acid-glycoprotein protects against trauma-hemorrhagic shock. J Surg Res. 2004;119(1):21–28. doi:10.1016/j.jss.2003.07.007
  • Lasson A, Berling R, Göransson J, Ohlsson K. Alpha-2-macroglobulin decreases parallel to albumin and haemoglobin after elective surgery. Scand J Clin Lab Invest. 1991;51(3):225–233. doi:10.3109/00365519109091609
  • Shahidi M. Thrombosis and von Willebrand factor. Adv Exp Med Biol. 2017;906:285–306.
  • Gelardi M, La Mantia I, Drago L, et al. A probiotic mixture in patients with upper respiratory diseases: the point of view of the otorhinolaringologist. J Biol Regul Homeost Agents. 2020;34(6Suppl. 1):5–10.
  • Conti P, Caraffa A, Gallenga CE, et al. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy. J Biol Regul Homeost Agents. 2020;34(6):1971–1975.
  • Cahill LA, Guo F, Nguyen J, et al. Circulating factors in trauma plasma activate specific human immune cell subsets. Injury. 2020;51(4):819–829. doi:10.1016/j.injury.2020.03.009
  • Isoda K, Shiigai M, Ishigami N, et al. Deficiency of interleukin-1 receptor antagonist promotes neointimal formation after injury. Circulation. 2003;108(5):516–518. doi:10.1161/01.CIR.0000085567.18648.21
  • Cahill LA, Joughin BA, Kwon WY, et al. Multiplexed plasma immune mediator signatures can differentiate sepsis from NonInfective SIRS: American Surgical Association 2020 annual meeting paper. Ann Surg. 2020;272(4):604–610. doi:10.1097/SLA.0000000000004379
  • Wang J, Vodovotz Y, Fan L, et al. Injury-induced MRP8/MRP14 stimulates IP-10/CXCL10 in monocytes/macrophages. FASEB J. 2015;29(1):250–262. doi:10.1096/fj.14-255992
  • Conti P, Younes A. Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection. J Biol Regul Homeost Agents. 2020;34(2):339–343.
  • Eidelberg A, Kirubakaran R, Nair SC, Eapen CE, Elias E, Goel A. Systematic review: role of elevated plasma von-Willebrand factor as predictor of mortality in patients with chronic liver disease. Eur J Gastroenterol Hepatol. 2019;31(10):1184–1191. doi:10.1097/MEG.0000000000001491
  • Parissis JT, Korovesis S, Giazitzoglou E, Kalivas P, Katritsis D. Plasma profiles of peripheral monocyte-related inflammatory markers in patients with arterial hypertension. Correlations with plasma endothelin-1. Int J Cardiol. 2002;83(1):13–21. doi:10.1016/S0167-5273(02)00021-9
  • Rincon M, Irvin CG. Role of IL-6 in asthma and other inflammatory pulmonary diseases. Int J Biol Sci. 2012;8(9):1281–1290. doi:10.7150/ijbs.4874
  • Amaral Pedroso L, Nobre V, Dias Carneiro de Almeida C, et al. Acute kidney injury biomarkers in the critically ill. Clin Chim Acta. 2020;508:170–178. doi:10.1016/j.cca.2020.05.024
  • Palma Dos Reis AF, Hennig I, Wilcock A. Immune checkpoint inhibitors: current status. BMJ Support Palliat Care. 2021. doi:10.1136/bmjspcare-2021-002954